Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 
Chinese Cars in Europe: Consumer Trust Is Shifting Fast 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict 
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
OpenAI Addresses Security Vulnerability in macOS App Certification Process 
NORFOLK, Va., Feb. 15, 2017 -- Beaufort, a contract research organization (CRO) and consultancy, has obtained ISO 9001:2015 certification. The certification demonstrates that Beaufort provides consistently good quality services to the life sciences industry in its clinical research, regulatory affairs, quality, and staffing solutions.
“We are proud that Beaufort is one of very few CROs to obtain ISO certification,” said Beaufort President Clay Gill. “This certification reflects Beaufort’s rigorous dedication to meeting client requirements, upholding the highest quality standards, and continuously improving processes throughout our organization.”
Gill continued, “Sponsors can be confident that their projects will be conducted with the highest quality management principles and process-driven methodologies.”
ISO (International Organization for Standardization) is an independent, non-governmental worldwide federation that develops international standards. ISO 9001:2015, the latest edition of ISO’s flagship quality management systems standard, is a worldwide quality standard that helps organizations demonstrate that they offer products and services of consistently good quality.
“We believe a well-structured quality system is critical to the success of our clients’ work. This ISO certification provides third party validation of our commitment to a quality-first approach and helps further set Beaufort apart from other CROs,” explained John R. Wilson Jr., PhD, MPH, Beaufort senior vice president of clinical development and quality solutions.
To obtain ISO 9001:2015 certification, a firm must demonstrate that it: practices evidence-based decision making; addresses risks and opportunities in a methodical manner; and ensures that quality policy and quality objectives are established for the quality management system that are compatible with the context and strategic direction of the organization.
Beaufort’s independent assessment and certification was performed by accredited registrar Integrated Management Systems Group (IMSG).
About Beaufort, LLC
Beaufort, LLC, is a contract research organization that provides in vitro diagnostic, medical device and biopharmaceutical clinical and regulatory services, and a full range of quality solutions and staffing solutions. For more than a decade, companies worldwide have trusted Beaufort for its client-oriented approach to research. With operations spanning the globe, Beaufort has a proven track record working closely with clients and regulatory agencies internationally to bring complex and therapeutic-specific products to market. Learn more at www.BeaufortCRO.com.
Jennifer Petit (757) 656-9763 [email protected]
